More about High-Yield Cash Accounts with M1
Brokerage Accounts
Retirement Accounts
Other Accounts
Quotes are delayed by 15 minutes.
1D
1W
1M
3M
6M
YTD
1Y
2Y
5Y
ALL
Market cap
$63.06B
EPS
7.73
P/E ratio
32.8
Price to sales
0.22
Dividend yield
0.756%
Beta
0.525246
Previous close
$272.34
Today's open
$276.52
Day's range
$271.98 - $277.72
52 week range
$180.45 - $286.29
show more
CEO
Jason M. Hollar
Employees
63900
Headquarters
Dublin, OH
Exchange
New York Stock Exchange
Shares outstanding
231136655
Issue type
Common Stock
Healthcare
Medical Distributors
Jim Cramer Says Cardinal Health Is “the Stock That Is Made for This Moment”
A drug distributor earning pennies on every dollar just beat estimates, raised guidance, and caught Jim Cramer's eye. But with the shares already up sharply this year, does the defensive pitch still leave room for new buyers?
24/7 Wall Street • Nov 20, 2026

4 High-Yield Healthcare Stocks Retirees Should Buy for December Income
Healthcare demand holds up when the economy slows, which makes the sector a natural place for retirees to look for income heading into the new year. The quality of that income varies widely, though.
24/7 Wall Street • Nov 18, 2026

Worried investors are paying up for these stocks — some with up to 49% upside, analysts say
Defensive sectors have beaten the S&P 500 by a wide margin in recent months, even though they are priced much higher relative to earnings estimates than the index.
Market Watch • Nov 18, 2026

Why Cardinal Health (CAH) is a Top Value Stock for the Long-Term
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
Zacks Investment Research • Nov 17, 2026

Cardinal Health (CAH) is a Top-Ranked Growth Stock: Should You Buy?
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
Zacks Investment Research • Nov 16, 2026

5 Dividend Growth Stocks to Buy as NVDA CEO Resignation Rattles Market
NVIDIA CEO Jensen Huang's resignation and market volatility bring into the spotlight five dividend growth stocks with earnings growth potential.
Zacks Investment Research • Nov 16, 2026

Wall Street Analysts Think Cardinal (CAH) Is a Good Investment: Is It?
Investors often turn to recommendations made by Wall Street analysts before making a Buy, Sell, or Hold decision about a stock. While media reports about rating changes by these brokerage-firm employed (or sell-side) analysts often affect a stock's price, do they really matter?
Zacks Investment Research • Nov 13, 2026

Cardinal Health Board of Directors Approves Quarterly Dividend
DUBLIN, Ohio, Nov. 11, 2026 /PRNewswire/ -- Cardinal Health (NYSE: CAH) announced today that its Board of Directors approved its quarterly dividend of $0.5158 per share, out of the Company's capital surplus. The dividend will be payable on January 15, 2027 to shareholders of record at the close of business on January 4, 2027.
PRNewsWire • Nov 11, 2026

Here's Why Cardinal Health (CAH) is a Great Momentum Stock to Buy
Does Cardinal Health (CAH) have what it takes to be a top stock pick for momentum investors? Let's find out.
Zacks Investment Research • Nov 11, 2026

Cardinal (CAH) is an Incredible Growth Stock: 3 Reasons Why
Cardinal (CAH) could produce exceptional returns because of its solid growth attributes.
Zacks Investment Research • Nov 10, 2026

¹ Disclosures

Open an M1 investment account to buy and sell Cardinal Health Inc. commission-free¹. Build wealth for the long term using automated trading and transfers.